Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

An RNA-centric dissection of host complexes controlling flavivirus infection.

Ooi YS, Majzoub K, Flynn RA, Mata MA, Diep J, Li JK, van Buuren N, Rumachik N, Johnson AG, Puschnik AS, Marceau CD, Mlera L, Grabowski JM, Kirkegaard K, Bloom ME, Sarnow P, Bertozzi CR, Carette JE.

Nat Microbiol. 2019 Aug 5. doi: 10.1038/s41564-019-0518-2. [Epub ahead of print]

PMID:
31384002
2.

Impact of a patient-derived hepatitis C viral RNA genome with a mutated microRNA binding site.

Mata M, Neben S, Majzoub K, Carette J, Ramanathan M, Khavari PA, Sarnow P.

PLoS Pathog. 2019 May 10;15(5):e1007467. doi: 10.1371/journal.ppat.1007467. eCollection 2019 May.

3.

A transfer-RNA-derived small RNA regulates ribosome biogenesis.

Kim HK, Fuchs G, Wang S, Wei W, Zhang Y, Park H, Roy-Chaudhuri B, Li P, Xu J, Chu K, Zhang F, Chua MS, So S, Zhang QC, Sarnow P, Kay MA.

Nature. 2017 Dec 7;552(7683):57-62. doi: 10.1038/nature25005. Epub 2017 Nov 29.

4.

Precursor microRNA-122 inhibits synthesis of Insig1 isoform mRNA by modulating polyadenylation site usage.

Norman KL, Chen TC, Zeiner G, Sarnow P.

RNA. 2017 Dec;23(12):1886-1893. doi: 10.1261/rna.063099.117. Epub 2017 Sep 19.

5.

Trans-kingdom mimicry underlies ribosome customization by a poxvirus kinase.

Jha S, Rollins MG, Fuchs G, Procter DJ, Hall EA, Cozzolino K, Sarnow P, Savas JN, Walsh D.

Nature. 2017 Jun 29;546(7660):651-655. doi: 10.1038/nature22814. Epub 2017 Jun 21.

6.

Making the Mark: The Role of Adenosine Modifications in the Life Cycle of RNA Viruses.

Gonzales-van Horn SR, Sarnow P.

Cell Host Microbe. 2017 Jun 14;21(6):661-669. doi: 10.1016/j.chom.2017.05.008. Review.

7.

Correction for Doukas and Sarnow, "Escape from Transcriptional Shutoff during Poliovirus Infection: NF-κB-Responsive Genes IκBa and A20".

Doukas T, Sarnow P.

J Virol. 2017 Apr 13;91(9). pii: e00223-17. doi: 10.1128/JVI.00223-17. Print 2017 May 1. No abstract available.

8.

Unraveling the Mysterious Interactions Between Hepatitis C Virus RNA and Liver-Specific MicroRNA-122.

Sarnow P, Sagan SM.

Annu Rev Virol. 2016 Sep 29;3(1):309-332. Epub 2016 Aug 17. Review.

PMID:
27578438
9.

Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens.

Marceau CD, Puschnik AS, Majzoub K, Ooi YS, Brewer SM, Fuchs G, Swaminathan K, Mata MA, Elias JE, Sarnow P, Carette JE.

Nature. 2016 Jul 7;535(7610):159-63. Epub 2016 Jun 17.

10.

Supporting Role for GTPase Rab27a in Hepatitis C Virus RNA Replication through a Novel miR-122-Mediated Effect.

Chen TC, Hsieh CH, Sarnow P.

PLoS Pathog. 2015 Aug 25;11(8):e1005116. doi: 10.1371/journal.ppat.1005116. eCollection 2015 Aug.

11.

Interaction of host cell microRNAs with the HCV RNA genome during infection of liver cells.

Sedano CD, Sarnow P.

Semin Liver Dis. 2015 Feb;35(1):75-80. doi: 10.1055/s-0034-1397351. Epub 2015 Jan 29. Review.

12.

cis-Acting RNA elements in the hepatitis C virus RNA genome.

Sagan SM, Chahal J, Sarnow P.

Virus Res. 2015 Aug 3;206:90-8. doi: 10.1016/j.virusres.2014.12.029. Epub 2015 Jan 7. Review.

13.

Kinetic pathway of 40S ribosomal subunit recruitment to hepatitis C virus internal ribosome entry site.

Fuchs G, Petrov AN, Marceau CD, Popov LM, Chen J, O'Leary SE, Wang R, Carette JE, Sarnow P, Puglisi JD.

Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):319-25. doi: 10.1073/pnas.1421328111. Epub 2014 Dec 16.

14.

Dissecting noncoding and pathogen RNA-protein interactomes.

Flynn RA, Martin L, Spitale RC, Do BT, Sagan SM, Zarnegar B, Qu K, Khavari PA, Quake SR, Sarnow P, Chang HY.

RNA. 2015 Jan;21(1):135-43. doi: 10.1261/rna.047803.114. Epub 2014 Nov 19.

15.

Hepatitis C virus subverts liver-specific miR-122 to protect the viral genome from exoribonuclease Xrn2.

Sedano CD, Sarnow P.

Cell Host Microbe. 2014 Aug 13;16(2):257-264. doi: 10.1016/j.chom.2014.07.006.

16.

Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension.

Sawada H, Saito T, Nickel NP, Alastalo TP, Glotzbach JP, Chan R, Haghighat L, Fuchs G, Januszyk M, Cao A, Lai YJ, Perez Vde J, Kim YM, Wang L, Chen PI, Spiekerkoetter E, Mitani Y, Gurtner GC, Sarnow P, Rabinovitch M.

J Exp Med. 2014 Feb 10;211(2):263-80. doi: 10.1084/jem.20111741. Epub 2014 Jan 20.

17.

Molecular biology. RNAi, Antiviral after all.

Sagan SM, Sarnow P.

Science. 2013 Oct 11;342(6155):207-8. doi: 10.1126/science.1245475. No abstract available.

PMID:
24115433
18.

Enhancement of hepatitis C viral RNA abundance by precursor miR-122 molecules.

Cox EM, Sagan SM, Mortimer SA, Doudna JA, Sarnow P.

RNA. 2013 Dec;19(12):1825-32. doi: 10.1261/rna.040865.113. Epub 2013 Oct 8.

19.

Modulation of GB virus B RNA abundance by microRNA-122: dependence on and escape from microRNA-122 restriction.

Sagan SM, Sarnow P, Wilson JA.

J Virol. 2013 Jul;87(13):7338-47. doi: 10.1128/JVI.00378-13. Epub 2013 Apr 24.

20.

Micromanaging hepatitis C virus.

Lieberman J, Sarnow P.

N Engl J Med. 2013 May 2;368(18):1741-3. doi: 10.1056/NEJMe1301348. Epub 2013 Mar 27. No abstract available.

PMID:
23534545
21.

Modulation of hepatitis C virus RNA abundance and virus release by dispersion of processing bodies and enrichment of stress granules.

Pager CT, Schütz S, Abraham TM, Luo G, Sarnow P.

Virology. 2013 Jan 20;435(2):472-84. doi: 10.1016/j.virol.2012.10.027. Epub 2012 Nov 9.

22.

Reduced DEAF1 function during type 1 diabetes inhibits translation in lymph node stromal cells by suppressing Eif4g3.

Yip L, Creusot RJ, Pager CT, Sarnow P, Fathman CG.

J Mol Cell Biol. 2013 Apr;5(2):99-110. doi: 10.1093/jmcb/mjs052. Epub 2012 Aug 24.

23.

Combating hepatitis C virus by targeting microRNA-122 using locked nucleic acids.

Machlin ES, Sarnow P, Sagan SM.

Curr Gene Ther. 2012 Aug;12(4):301-6. Review.

PMID:
22856605
24.

MicroRNA silencing and the development of novel therapies for liver disease.

Szabo G, Sarnow P, Bala S.

J Hepatol. 2012 Aug;57(2):462-6. doi: 10.1016/j.jhep.2012.01.030. Epub 2012 Apr 12. Review.

25.

Escape from transcriptional shutoff during poliovirus infection: NF-κB-responsive genes IκBa and A20.

Doukas T, Sarnow P.

J Virol. 2011 Oct;85(19):10101-8. doi: 10.1128/JVI.00575-11. Epub 2011 Jul 27. Erratum in: J Virol. 2017 Apr 13;91(9):.

26.

Proteomic analysis of ribosomes: translational control of mRNA populations by glycogen synthase GYS1.

Fuchs G, Diges C, Kohlstaedt LA, Wehner KA, Sarnow P.

J Mol Biol. 2011 Jul 1;410(1):118-30. doi: 10.1016/j.jmb.2011.04.064. Epub 2011 May 5.

27.

RNA virus harnesses microRNAs to seize host translation control.

Abraham TM, Sarnow P.

Cell Host Microbe. 2011 Jan 20;9(1):5-7. doi: 10.1016/j.chom.2011.01.004.

28.

Masking the 5' terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex.

Machlin ES, Sarnow P, Sagan SM.

Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3193-8. doi: 10.1073/pnas.1012464108. Epub 2011 Jan 10.

29.

Herpes Simplex Virus is Akt-ing in translational control.

Norman KL, Sarnow P.

Genes Dev. 2010 Dec 1;24(23):2583-6. doi: 10.1101/gad.2004510.

30.

Hepatitis C virus core-derived peptides inhibit genotype 1b viral genome replication via interaction with DDX3X.

Sun C, Pager CT, Luo G, Sarnow P, Cate JH.

PLoS One. 2010 Sep 17;5(9). pii: e12826. doi: 10.1371/journal.pone.0012826.

31.

Plasmacytoid dendritic cells as guardians in hepatitis C virus-infected liver.

Sagan SM, Sarnow P.

Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7625-6. doi: 10.1073/pnas.1002943107. Epub 2010 Apr 19. No abstract available.

32.

Hepatitis C virus' Achilles' heel--dependence on liver-specific microRNA miR-122.

Norman KL, Sarnow P.

Cell Res. 2010 Mar;20(3):247-9. doi: 10.1038/cr.2010.28. No abstract available.

PMID:
20190773
33.

Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems.

Parameswaran P, Sklan E, Wilkins C, Burgon T, Samuel MA, Lu R, Ansel KM, Heissmeyer V, Einav S, Jackson W, Doukas T, Paranjape S, Polacek C, dos Santos FB, Jalili R, Babrzadeh F, Gharizadeh B, Grimm D, Kay M, Koike S, Sarnow P, Ronaghi M, Ding SW, Harris E, Chow M, Diamond MS, Kirkegaard K, Glenn JS, Fire AZ.

PLoS Pathog. 2010 Feb 12;6(2):e1000764. doi: 10.1371/journal.ppat.1000764.

34.

OGFOD1, a novel modulator of eukaryotic translation initiation factor 2alpha phosphorylation and the cellular response to stress.

Wehner KA, Schütz S, Sarnow P.

Mol Cell Biol. 2010 Apr;30(8):2006-16. doi: 10.1128/MCB.01350-09. Epub 2010 Feb 12.

35.

Stable formation of compositionally unique stress granules in virus-infected cells.

Piotrowska J, Hansen SJ, Park N, Jamka K, Sarnow P, Gustin KE.

J Virol. 2010 Apr;84(7):3654-65. doi: 10.1128/JVI.01320-09. Epub 2010 Jan 27.

36.

Temperature protects insect cells from infection by cricket paralysis virus.

Cevallos RC, Sarnow P.

J Virol. 2010 Feb;84(3):1652-5. doi: 10.1128/JVI.01730-09. Epub 2009 Nov 11.

37.
38.

The Imd pathway is involved in antiviral immune responses in Drosophila.

Costa A, Jan E, Sarnow P, Schneider D.

PLoS One. 2009 Oct 15;4(10):e7436. doi: 10.1371/journal.pone.0007436.

39.

LC3-mediated fibronectin mRNA translation induces fibrosarcoma growth by increasing connective tissue growth factor.

Ying L, Lau A, Alvira CM, West R, Cann GM, Zhou B, Kinnear C, Jan E, Sarnow P, Van de Rijn M, Rabinovitch M.

J Cell Sci. 2009 May 1;122(Pt 9):1441-51. doi: 10.1242/jcs.025957. Epub 2009 Apr 14.

40.

Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs.

Gu S, Jin L, Zhang F, Sarnow P, Kay MA.

Nat Struct Mol Biol. 2009 Feb;16(2):144-50. doi: 10.1038/nsmb.1552. Epub 2009 Feb 1.

41.

MicroRNA-mediated gene silencing.

Pager CT, Wehner KA, Fuchs G, Sarnow P.

Prog Mol Biol Transl Sci. 2009;90:187-210. doi: 10.1016/S1877-1173(09)90005-9. Epub 2009 Oct 27. Review.

PMID:
20374742
42.

Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome.

Jopling CL, Schütz S, Sarnow P.

Cell Host Microbe. 2008 Jul 17;4(1):77-85. doi: 10.1016/j.chom.2008.05.013.

43.

LNA-mediated microRNA silencing in non-human primates.

Elmén J, Lindow M, Schütz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjärn M, Hansen HF, Berger U, Gullans S, Kearney P, Sarnow P, Straarup EM, Kauppinen S.

Nature. 2008 Apr 17;452(7189):896-9. doi: 10.1038/nature06783. Epub 2008 Mar 26.

PMID:
18368051
44.

How viruses avoid stress.

Schütz S, Sarnow P.

Cell Host Microbe. 2007 Nov 15;2(5):284-5. Review.

45.

Inhibition of U snRNP assembly by a virus-encoded proteinase.

Almstead LL, Sarnow P.

Genes Dev. 2007 May 1;21(9):1086-97.

46.

Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122.

Jopling CL, Norman KL, Sarnow P.

Cold Spring Harb Symp Quant Biol. 2006;71:369-76. Review.

PMID:
17381319
47.

MicroRNAs: expression, avoidance and subversion by vertebrate viruses.

Sarnow P, Jopling CL, Norman KL, Schütz S, Wehner KA.

Nat Rev Microbiol. 2006 Sep;4(9):651-9. Review.

PMID:
16912711
48.

Polypyrimidine tract binding protein regulates IRES-mediated gene expression during apoptosis.

Bushell M, Stoneley M, Kong YW, Hamilton TL, Spriggs KA, Dobbyn HC, Qin X, Sarnow P, Willis AE.

Mol Cell. 2006 Aug 4;23(3):401-12.

49.

Initiation factor-independent translation mediated by the hepatitis C virus internal ribosome entry site.

Lancaster AM, Jan E, Sarnow P.

RNA. 2006 May;12(5):894-902. Epub 2006 Mar 23.

50.

Interaction of viruses with the mammalian RNA interference pathway.

Schütz S, Sarnow P.

Virology. 2006 Jan 5;344(1):151-7. Review.

Supplemental Content

Loading ...
Support Center